FDA Lets GSK/Adolor Resume Entereg Work

But regulatory hurdles could send GSK on its way, analysts say.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet